AC
ROIV icon

AXQ Capital’s Roivant Sciences ROIV Stock Holding History

AXQ Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Sell
39,712
-92,755
-70% -$2.74M 0.15% 212
2026
Q1 		$3.67M Buy
132,467
+104,588
+375% +$2.69M 0.47% 26
2025
Q4 		$605K Buy
27,879
+14,898
+115% +$294K 0.14% 249
2025
Q3 		$196K Buy
12,981
+41
+0.3% +$508 0.08% 455
2025
Q2 		$146K Sell
12,940
-26,586
-67% -$288K 0.05% 488
2025
Q1 		$399K Buy
+39,526
New +$427K 0.16% 237
2024
Q2 		– Sell
-42,700
Closed -$450K – 683
2024
Q1 		$450K Buy
+42,700
New +$460K 0.11% 326

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AXQ Capital's ROIV Position: Q2 2026 in Review

AXQ Capital reduced its Roivant Sciences (ROIV) stake by 70% in Q2 2026, selling an estimated $2.74M and leaving 39,712 shares worth $1.41M. The position accounts for 0.15% of the portfolio, ranked #212.

AXQ Capital first reported a position in ROIV in Q1 2024 and has held it in 7 quarters since. The position peaked at $3.67M in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • AXQ Capital held 39,712 shares of Roivant Sciences worth $1.41M as of Q2 2026.
  • AXQ Capital sold 92,755 Roivant Sciences shares in Q2 2026, an estimated $2.74M.
  • Roivant Sciences made up 0.15% of AXQ Capital's portfolio in Q2 2026, its #212 holding.
  • AXQ Capital first reported a position in Roivant Sciences in Q1 2024 and has held it in 7 quarters since.
  • AXQ Capital's Roivant Sciences position peaked at $3.67M in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.